Tazemetostat hydrobromide T17002
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Tazemetostat hydrobromide is a potent and selective EZH2 inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 (Ki: 2.5 nM). Tazemetostat hydrobromide also inhibits EZH1 (IC50: 3
CAS nr:
1467052-75-0
Purity:
98%
Molecular Weight:
653,65
SMILES:
O=C(C1=CC(C2=CC=C(CN3CCOCC3)C=C2)=CC(N(CC)C4CCOCC4)=C1C)NCC5=C(C)C=C(C)NC5=O.[H]Br
Formula:
C34H45BrN4O4
Pathway:
Chromatin/Epigenetic
Target:
Histone Methyltransferase
